Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117279) titled 'A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma' on Aug. 5.
Study Type: Observational [Patient Registry]
Primary Sponsor: Tongji Hospital
Condition:
HCC - Hepatocellular Carcinoma
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 120
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117279
Published by HT Digital Content Services with permission from Health Daily Digest....